Answers are grounded in this paper and cite their sources.
This review examines integrating machine learning with pharmacokinetic and pharmacodynamic modeling to enhance medication dosing accuracy in the geriatric population, suggesting improved clinical...
Geriatric pharmacotherapy is usually challenged by physiological senescence. For instance, progressive declines in organ function and alterations in body composition can complicate drug disposition. However, conventional pharmacometrics models commonly have limited capacity to map these high-dimensional, nonlinear relationships. In this review, we are examining the recent shift toward integrating machine learning (ML) with mechanistic pharmacokinetic (PK)/pharmacodynamic (PD) models to improve the accuracy and precision of dosing. Machine learning approaches like Random Forest and XGBoost consistently provided more accurate exposure predictions and significantly more efficient computational workflows than conventional methods. Nevertheless, concerns such as “black box” transparency and the potential of algorithmic bias toward specific patient demographics are challenging. It is important to incorporate explainability tools like SHAP, and adopting FAIR data principles is crucial for achieving professional trust and ensuring site-specific generalizability.
No takes yet. Share an insight, caveat, or question.
Alsayed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: